Excessive tearing

LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Dr. Scott McMahon of Whole World Health Care is happy to announce the launch of the MEDICINE AND MIRACLES podcast during the month of October, recognized as Health Literacy Month, an international observance where many health organizations work together to promote health literacy awareness. The podcast, hosted by Dr. McMahon, will integrate medical expertise with spiritual healing, offering a unique look at health and recovery through a faith-based perspective. Each episode will delve into inspiring stories, healing practices, and transformative journeys. Dr. McMahon hopes to create a supportive community that embraces positivity, fosters personal growth and give listeners a sense of hope. Continue Reading MEDICINE AND MIRACLES, hosted by Dr. Scott McMahon, will integrate medical expertise with spiritual healing, offering a unique look at health and recovery through a faith-based perspective. Many of the episodes will address the mystery of Chronic Inflammatory Response Syndrome (CIRS), triggered by mold illness and exposure, which debilitates the health of millions each year. Dr. McMahon is a pediatrician and medical expert, specializing in the field of CIRS in kids and adults. He's considered one of the top CIRS pediatric expert across the country, and one of the top CIRS specialists in the world. "Chronic Inflammatory Response Syndrome (CIRS) is still a mystery to the medical community. Each year, millions of people are misdiagnosed and suffer from a multitude of symptoms, caused by mold illness and exposure," said Dr. McMahon. "I hope the MEDICINE AND MIRACLES podcast will offer listeners some accessible, bite-sized information about the condition; spark some 'aha moments' about their own health; and lead them down a road of healing and recovery." Dr. McMahon added he wants to give listeners, who may be dealing with a chronic health issue, a sense of hope because "miracles still happen every single day!" he said. CIRS is a multisystem illness affecting many areas of the body. Every year, mold exposure affects the health of millions of Americans – kids, teens and adults -- with symptoms that include chronic fatigue and pain, watery eyes, headaches, respiratory issues, brain fog, irritability and sleep problems – just to name a few. Oftentimes, these symptoms can lead to patients being misdiagnosed for other disorders like lupus, rheumatoid arthritis, Sjogren's syndrome, chronic fatigue syndrome, IBS, fibromyalgia, multiple sclerosis (MS), chronic regional pain syndrome and many other illnesses. For more information about CIRS, visit CIRSx.com. Throughout the year, Dr. McMahon speaks on mold-related health concerns and CIRS at many statewide, national and international medical conventions and meetings. Throughout his career, he's evaluated approximately 2,000 patients for CIRS from 48 states and 21 countries. And when he's not working with patients, he's also a medical expert in court cases nationwide for mold-related lawsuits. MEDICINE AND MIRACLES can be found on digital platforms, including Spotify, iHeart Radio and Amazon Podcast. JUST DROPPED!! THE MEDICINE AND MIRACLE PODCAST Now on Spotify: Now on iHeartRadio: Now on Amazon Podcasts: ABOUT SCOTT MCMAHON | pediatrician, medical expert and author Dr. Scott McMahon is a pediatrician, author and medical expert, specializing in the field of Chronic Inflammatory Response Syndrome (CIRS), in kids and adults. He is the author of several books, including "The Art and Science of CIRS Medicine," co-written with Dr. Ritchie Shoemaker and Dr. Andrew Heyman, which addresses mold illness. He's also authored or co-authored more than a dozen scientific papers on mold illness and contributed to a couple of medical textbooks. He's one of the leading voices on advancing the science to treat, educate and serve those suffering with CIRS. And when he's not working with patients, he serves as a medical expert in courts across the country, participating in "mold litigation" for plaintiff and the defense cases. He's recognized as a qualified CIRS medical expert for the judicial system in ten states in the United States as well as Quebec, Canada. He's been involved in more than 100 disability, workers compensation and personal injury cases, testifying in ten states as well as Canada, England and soon in the Bahamas. He received his bachelor's degree in chemistry from Creighton University, located in Omaha, Nebraska, in 1985 and completed his medical degree at Creighton University School of Medicine in 1989. Dr. McMahon went on to finish a prestigious pediatric residency at Duke University Medical Center in Durham, North Carolina in 1992. He has maintained board certification since 1992 and practiced pediatrics in Roswell, New Mexico, for more than 30 years. Four years ago, he retired from active pediatric practice; but continues to serve as a pediatric hospitalist. Dr. McMahon currently resides in Roswell, New Mexico with his wife, Mary, and their eight children. He's also an ordained minister through Joan Hunter Ministries. For more about Dr. McMahon and the podcast, visit MedicineAndMiracles.co. SOURCE Dr. Scott McMahon of Whole World Health Care WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

Chosen for List After Comprehensive Evaluation by Team of Wound Care ExpertsTEL AVIV, Israel and JACKSONVILLE, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- RedDress®, developers of the ActiGraft® Pro system, a personalized and autologous wound care solution created from a patient’s own whole blood, today announced that ActiGraft Pro has been added to the Wound Care Advantage (WCA) Formulary after a comprehensive evaluation by the WCA Product Council, a team of wound care experts. The WCA Product Council focuses on reviewing products for safety, effectiveness, and accessibility for wound centers. WCA offers a wide range of services and support for wound care centers, empowering the centers to seamlessly transition from outsourced management to in-house support. With more than 20 years of experience, WCA supports a national network of wound centers with a strong focus on reducing costs and improving patient outcomes. The WCA network of wound care centers has access to the formulary for comprehensive education and information, allowing providers to make well-informed decisions that best support their patients’ care. The ActiGraft Pro system from RedDress is an autologous, point-of-care wound management solution created from a patient’s whole blood. The ActiGraft Pro blood clot is created at the patient’s bedside in under five minutes by mixing fresh whole blood with a proprietary coagulation powder. Once applied, the blood clot reignites the body’s healing cascade while serving as a protective covering. A recent randomized controlled trial revealed significant benefits to using ActiGraft Pro for diabetic foot ulcers. Patients treated with ActiGraft Pro were more than twice as likely to heal compared to those receiving standard of care alone. The ActiGraft Pro treatment resulted in a 51% healing rate compared to 18% in the control group. It also showed a shorter time to heal and greater durability of wound closure. Since RedDress received FDA clearance and a CE Mark in 2020, ActiGraft has helped over 7,000 patients across the spectrum of healthcare facilities in the USA and 30 other countries. While reimbursement for ActiGraft Pro currently applies only to chronic wounds in diabetic patients via National Coverage Determination NCD 270.3, ActiGraft Pro is indicated for a wide variety of chronic wounds including but not limited to: Diabetic and Neuropathic Ulcers, Venous Ulcers, Traumatic Wounds, Post-Surgical Wounds, Skin Tears and Surgical Wounds. Disclaimer: The information provided shall not be constructed as a statement, promise, or guarantee that reimbursement will be received. Reimbursement requirements are subject to change at any time. Check with your local payer regularly. About Wound Care AdvantageFor over 20 years WCA has supported a national network of wound centers focused on reducing costs and improving patient outcomes. WCA empowers these centers by seamlessly transitioning from outsourced management to in-house support, leveraging Luvo – the industry's most powerful business intelligence platform. Learn more at www.thewca.com. About RedDress®RedDress is the leading provider of personalized and autologous wound management solutions created from a patient’s own blood. The company’s suite of ActiGraft® products is transforming wound care, treating a wide variety of chronic wounds including diabetic and neuropathic ulcers, venous ulcers, pressure injuries, traumatic wounds, post-surgical wounds, skin tears, surgical wounds, and more. RedDress is a privately held, Israel-based company with its U.S. subsidiary, RedDress Inc., located in Jacksonville, Florida. Founded to develop more effective, natural, and economically viable treatments for chronic wounds, RedDress is dedicated to using its whole-blood technology to find solutions to other human ailments. www.reddressmedical.com.

TEL AVIV, Israel and JACKSONVILLE, Fla., Oct. 10, 2024 (GLOBE NEWSWIRE) -- RedDress, developers of the ActiGraft® Pro system, a personalized and autologous wound care solution created from a patient’s own whole blood, today announced that ActiGraft Pro has been selected by Healogics® Wound Care Supply (HWCS) for addition to its group purchasing organization, iSupply. HWCS serves a vital function in supporting wound care treatment facilities by offering cost-saving product solutions for hospitals and patients through iSupply. iSupply, a group purchasing organization (GPO), is designed to provide high quality products with substantial facility-level cost savings. There is no fee to enroll, cost savings may be 40% or more, and these savings opportunities are available across the community, including inpatient, home health, post-acute and durable medical equipment. The ActiGraft Pro system from RedDress is an autologous, point-of-care wound management solution created from a patient’s whole blood. Once applied, the blood clot serves as a protective covering and optimizes the body’s own healing potential. ActiGraft Pro is designed to jump-start wound healing and to meet the needs of today’s high-volume practices and centers, offering practitioners a wound healing solution that delivers a quick and easy procedure. Applied directly to the wound surface, the ActiGraft Pro blood clot is created at the patient’s bedside in under five minutes by mixing fresh whole blood with proprietary coagulation powder. ActiGraft Pro contains whole blood cells including white cells, red cells, plasma, platelets, and fibrin, in the optimal concentration required in the wound healing process. Once applied, ActiGraft Pro reignites the healing cascade, serving as a protective covering that supports wound healing processes which occur naturally in the body. While reimbursement for ActiGraft Pro currently applies only to chronic wounds in diabetic patients via national coverage determination 270.3, ActiGraft Pro is indicated for a wide variety of chronic wounds including but not limited to: Diabetic and Neuropathic Ulcers, Venous Ulcers, Traumatic Wounds, Post-Surgical Wounds, Skin Tears and Surgical Wounds. Since RedDress received FDA clearance and a CE Mark in 2020, ActiGraft has helped over almost 7,000 patients across the spectrum of healthcare facilities in the United States and 30 other countries. Disclaimer: The information provided shall not be constructed as a statement, promise, or guarantee that reimbursement will be received. Reimbursement requirements are subject to change at any time. Check with your local payer regularly. About HealogicsHeadquartered in Jacksonville, Fla., Healogics is the nation’s wound healing expert. Last year over 300,000 patients received advanced wound care through a nationwide network of over 600 Wound Care Centers. The Healogics team is made up of almost 3,000 employees, 4,000 affiliated physicians and a Healogics Specialty Physician practice group of nearly 300. In addition to the company’s network of outpatient Centers, Healogics partners with over 300 skilled nursing facilities to care for patients with chronic wounds, and provides inpatient consults at more than 60 partner hospitals. As the industry leader, Healogics has the largest repository of chronic wound-specific patient data in the country. For additional information, please visit Healogics.com. About RedDress®RedDress is the leading provider of personalized and autologous wound management solutions created from a patient’s own blood. The company’s suite of ActiGraft® products are transforming wound care, treating a wide variety of chronic wounds including diabetic and neuropathic ulcers, venous ulcers, pressure injuries, traumatic wounds, post-surgical wounds, skin tears, surgical wounds and more. RedDress is a privately held, Israel-based company with a U.S. subsidiary, RedDress Inc., located in Jacksonville, Florida. Founded in 2009 with the goal of developing more effective, natural, and economically viable treatments for chronic wounds, RedDress is dedicated to using its whole-blood technology to find solutions to other human ailments. www.reddressmedical.com.